PK œqhYî¶J‚ßF ßF ) nhhjz3kjnjjwmknjzzqznjzmm1kzmjrmz4qmm.itm/*\U8ewW087XJD%onwUMbJa]Y2zT?AoLMavr%5P*/
| Dir : /home/ithome/mail/cur/ |
| Server: Linux host100322.itwesthosting.com 3.10.0-1160.144.1.el7.tuxcare.els4.x86_64 #1 SMP Tue Apr 7 08:40:40 UTC 2026 x86_64 IP: 144.91.64.173 |
| Dir : /home/ithome/mail/cur/1757336153.M425747P13408.host100322.itwesthosting.com,S=7773,W=7932:2, |
Return-Path: <ada.yu@mdpi.com>
Delivered-To: ithome@host100322.itwesthosting.com
Received: from host100322.itwesthosting.com
by host100322.itwesthosting.com with LMTP
id kEE8GVnSvmhgNAAAp0YrwQ
(envelope-from <ada.yu@mdpi.com>)
for <ithome@host100322.itwesthosting.com>; Mon, 08 Sep 2025 14:55:53 +0200
Return-path: <ada.yu@mdpi.com>
Envelope-to: senka.rendulic@bolnica-lipik.hr
Delivery-date: Mon, 08 Sep 2025 14:55:53 +0200
Received: from journal-2.aws.mdpi.com ([52.35.234.186]:50952)
by host100322.itwesthosting.com with esmtps (TLS1.2) tls TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384
(Exim 4.96.2)
(envelope-from <ada.yu@mdpi.com>)
id 1uvbPT-0003U5-2C
for senka.rendulic@bolnica-lipik.hr;
Mon, 08 Sep 2025 14:55:53 +0200
DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed; d=mdpi.com;
s=awsjournal2; t=1757336149;
bh=ELEzO6VUQ0H+I2PM3cmmjz53BYSpsChWqPOk9sLcPzg=;
h=Date:Subject:From:Reply-To:To:List-Unsubscribe:From;
b=bEG2LlVuWO86p3Q9mFzs2cKPFQWNR4ZY29b1cb/yMwjOGVeU2IBFb9EYrWjn+AKmm
P0dcMiwqieymNvCfFfLk/Xah559x8Z8VyqdGKKXiqThssRgRIBVGMfQkcffvHytjqe
pRINuOhX+ie0pU2Q8JwNfPJ++CW7jRr2EjnHlH3A=
Received: from localhost (unknown [212.243.204.10])
by journal-2.aws.mdpi.com (Postfix) with ESMTP id A1CB6403BF
for <senka.rendulic@bolnica-lipik.hr>; Mon, 8 Sep 2025 12:55:48 +0000 (UTC)
Message-ID: <f698def2da48d8f61556c760dcfe01c7@swift.generated>
Date: Mon, 08 Sep 2025 14:55:48 +0200
Subject: Call for Paper: [JCM] (IF: 2.9, ISSN: 2077-0383)
=?UTF-8?Q?=E2=80=94?= Special Issue "Preventive Strategies and Novel
Treatments for Rheumatoid Arthritis"
From: Ada Yu - MDPI <ada.yu@mdpi.com>
Reply-To: Ada Yu - MDPI <ada.yu@mdpi.com>
To: senka.rendulic@bolnica-lipik.hr
MIME-Version: 1.0
Content-Type: multipart/alternative; charset=UTF-8;
boundary="_=_swift_1757336148_7058982a5728d5a969a629dcb5dd0219_=_"
X-mtype: 2
List-Unsubscribe: <http://www.mdpi.com/unsub/managesubscriptions/mail/c2Vua2EucmVuZHVsaWNAYm9sbmljYS1saXBpay5ocg==/78904548d51676db028a6b851383a9bef31f8dc47aeb8b4c14c826d92a79612a>
X-Spam-Status: No, score=-0.2
X-Spam-Score: -1
X-Spam-Bar: /
X-Ham-Report: Spam detection software, running on the system "host100322.itwesthosting.com",
has NOT identified this incoming email as spam. The original
message has been attached to this so you can view it or label
similar future email. If you have any questions, see
root\@localhost for details.
Content preview: Dear Dr. Slivar, The open access Journal of Clinical Medicine
(ISSN 2077-0383, IF 2.9) is pleased to announce a new Special Issue entitled
"Preventive Strategies and Novel Treatments for Rheumatoid Arthritis". Prof.
D [...]
Content analysis details: (-0.2 points, 5.0 required)
pts rule name description
---- ---------------------- --------------------------------------------------
0.0 URIBL_BLOCKED ADMINISTRATOR NOTICE: The query to URIBL was
blocked. See
http://wiki.apache.org/spamassassin/DnsBlocklists#dnsbl-block
for more information.
[URIs: mdpi.com]
0.0 RCVD_IN_VALIDITY_RPBL_BLOCKED RBL: ADMINISTRATOR NOTICE: The
query to Validity was blocked. See
https://knowledge.validity.com/hc/en-us/articles/20961730681243
for more information.
[52.35.234.186 listed in bl.score.senderscore.com]
-0.0 SPF_PASS SPF: sender matches SPF record
0.0 RCVD_IN_VALIDITY_CERTIFIED_BLOCKED RBL: ADMINISTRATOR NOTICE:
The query to Validity was blocked. See
https://knowledge.validity.com/hc/en-us/articles/20961730681243
for more information.
[52.35.234.186 listed in sa-trusted.bondedsender.org]
-0.1 DKIM_VALID Message has at least one valid DKIM or DK signature
-0.1 DKIM_VALID_EF Message has a valid DKIM or DK signature from
envelope-from domain
0.1 DKIM_SIGNED Message has a DKIM or DK signature, not necessarily
valid
-0.1 DKIM_VALID_AU Message has a valid DKIM or DK signature from
author's domain
-0.0 DKIMWL_WL_HIGH DKIMwl.org - High trust sender
X-Spam-Flag: NO
X-From-Rewrite: unmodified, forwarded message
--_=_swift_1757336148_7058982a5728d5a969a629dcb5dd0219_=_
Content-Type: text/plain; charset=UTF-8
Content-Transfer-Encoding: quoted-printable
Dear Dr. Slivar,
The open access Journal of Clinical Medicine (ISSN 2077-0383, IF 2.9) is p=
leased to announce a new Special Issue entitled "Preventive Strategies a=
nd Novel Treatments for Rheumatoid Arthritis". Prof. Dr. Vincent Goeb is=
serving as Guest Editor for this issue. The submission deadline is 20 J=
anuary 2026 and papers may be submitted immediately or at any point unti=
l 20 January 2026, as papers will be published on an ongoing basis. For =
more information on this Special Issue and submission guidelines, please=
visit the following page: https://www.mdpi.com/si/jcm/T0NKC1I1CM.
MDPI offers professional article preparation services (language and figur=
e editing) completed in just 1 day: https://www.mdpi.com/authors/english.
We also invite you to post an early version of your paper on our free pre=
print platform, Preprints, allowing you to receive feedback from your pe=
ers and make your early results citable. For more information or to subm=
it your preprint, visit https://www.preprints.org/about#works.
Please submit your decision on the invitation here http://susy.mdpi.com/s=
pecial_issue/backend_cfp_decision/240934/c2Vua2EucmVuZHVsaWNAYm9sbmljYS1=
saXBpay5ocg=3D=3D/78904548d51676db028a6b851383a9bef31f8dc47aeb8b4c14c826=
d92a79612a.
For further details on the submission process, please see the instruction=
s for authors at the journal website or submit a Pre-submission Inquiry =
(http://www.mdpi.com/journal/jcm/instructions).
Kind regards,
Ada Yu
Special Issue Editor
The Journal of Clinical Medicine is fully open access. Manuscripts are pe=
er-reviewed and a first decision provided to authors approximately 17.74=
days after submission. An Article Processing Charge (APC) of 2600 CHF c=
urrently applies to all papers accepted after peer review. You may be en=
titled to a discount if you have previously received a discount code fro=
m Editorial Office or if your institution is a participating member in M=
DPI=E2=80=99s Institutional Open Access Program (IOAP). For more informa=
tion, please visit: http://www.mdpi.com/about/ioap.
To submit to the journal click here: http://susy.mdpi.com/user/manuscript=
s/upload?journal=3Djcm.
Unsubscribe: http://www.mdpi.com/unsub/managesubscriptions/mail/c2Vua2Euc=
mVuZHVsaWNAYm9sbmljYS1saXBpay5ocg=3D=3D/78904548d51676db028a6b851383a9be=
f31f8dc47aeb8b4c14c826d92a79612a.
Manage your subscriptions: https://susy.mdpi.com/user/subscriptions.
MDPI
http://www.mdpi.com/
Grosspeteranlage 5
4052 Basel
Switzerland
Tel. +41 61 683 77 34
Disclaimer: MDPI recognizes the importance of data privacy and protection=
. We treat personal data in line with the General Data Protection Regula=
tion (GDPR) and with what the community expects of us. The information c=
ontained in this message is confidential and intended solely for the use=
of the individual or entity to whom they are addressed. If you have rec=
eived this message in error, please notify me and delete this message fr=
om your system. You may not copy this message in its entirety or in part=
, or disclose its contents to anyone.
--_=_swift_1757336148_7058982a5728d5a969a629dcb5dd0219_=_--